Skip Header

25 results for author:"Schafer B.W." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (4)

CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres.

Walter D., Satheesha S., Albrecht P., Bornhauser B.C., D'Alessandro V., Oesch S.M., Rehrauer H., Leuschner I., Koscielniak E., Gengler C. et al.

PLoS ONE 6:e19506-e19506(2011) · Mapped (4)

Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics.

Grass B., Wachtel M., Behnke S., Leuschner I., Niggli F.K., Schafer B.W.

Histopathology 54:873-879(2009) · Mapped (33)

Diminished expression of S100A2, a putative tumour suppressor, is an independent predictive factor of neck node relapse in laryngeal squamous cell carcinoma.

Almadori G., Bussu F., Galli J., Rigante M., Lauriola L., Michetti F., Maggiano N., Schafer B.W., Heizmann C.W., Ranelletti F.O. et al.

J Otolaryngol Head Neck Surg 38:16-22(2009) · Mapped (1)

Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities.

Amstutz R., Wachtel M., Troxler H., Kleinert P., Ebauer M., Haneke T., Oehler-Janne C., Fabbro D., Niggli F.K., Schafer B.W.

Cancer Res. 68:3767-3776(2008) · Mapped (13)

Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR.

Ebauer M., Wachtel M., Niggli F.K., Schafer B.W.

Oncogene 26:7267-7281(2007) · Mapped (12)

The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity.

Mueller A., Schafer B.W., Ferrari S., Weibel M., Makek M., Hochli M., Heizmann C.W.

J. Biol. Chem. 280:29186-29193(2005) · Mapped (34)

Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene.

EL Naaman C., Grum-Schwensen B., Mansouri A., Grigorian M., Santoni-Rugiu E., Hansen T., Kriajevska M., Schafer B.W., Heizmann C.W., Lukanidin E. et al.

Oncogene 23:3670-3680(2004) · Mapped (3)

S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells.

Hsieh H.L., Schafer B.W., Weigle B., Heizmann C.W.

Biochem. Biophys. Res. Commun. 316:949-959(2004) · Mapped (2)

The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo.

Relaix F., Polimeni M., Rocancourt D., Ponzetto C., Schafer B.W., Buckingham M.

Genes Dev. 17:2950-2965(2003) · Mapped (15)

Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays.

Hsieh H.L., Schafer B.W., Sasaki N., Heizmann C.W.

Biochem. Biophys. Res. Commun. 307:375-381(2003) · Mapped (36)

Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart.

Kiewitz R., Acklin C., Schafer B.W., Maco B., Uhrik B., Wuytack F., Erne P., Heizmann C.W.

Biochem. Biophys. Res. Commun. 306:550-557(2003) · Mapped (8)

Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2.

Lange S., Auerbach D., McLoughlin P., Perriard E., Schafer B.W., Perriard J.-C., Ehler E.

J. Cell Sci. 115:4925-4936(2002) · UniProtKB (2) · Mapped (1)

The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein.

McLoughlin P., Ehler E., Carlile G., Licht J.D., Schafer B.W.

J. Biol. Chem. 277:37045-37053(2002) · Mapped (5)

S100A13 and S100A6 exhibit distinct translocation pathways in endothelial cells.

Hsieh H.L., Schafer B.W., Cox J.A., Heizmann C.W.

J. Cell. Sci. 115:3149-3158(2002)

Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family.

Pietas A., Schluns K., Marenholz I., Schafer B.W., Heizmann C.W., Petersen I.

Genomics 79:513-522(2002) · UniProtKB (1) · Mapped (2)

Ultrastructural distribution of the S100A1 Ca2+-binding protein in the human heart.

Maco B., Mandinova A., Durrenberger M.B., Schafer B.W., Uhrik B., Heizmann C.W.

Physiol Res 50:567-574(2001) · Mapped (2)

The Ca2+-binding S100A2 protein is differentially expressed in epithelial tissue of glandular or squamous origin.

Nagy N., Hoyaux D., Gielen I., Schafer B.W., Pochet R., Heizmann C.W., Kiss R., Salmon I., Decaestecker C.

Histol. Histopathol. 17:123-130(2002) · Mapped (1)

Transcriptional regulation of S100A1 and expression during mouse heart development.

Kiewitz R., Lyons G.E., Schafer B.W., Heizmann C.W.

Biochim. Biophys. Acta 1498:207-219(2000) · Mapped (4)

DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis.

Scholl F.A., McLoughlin P., Ehler E., de Giovanni C., Schafer B.W.

J. Cell Biol. 151:495-506(2000) · Mapped (1)

S100A1, a new marker for acute myocardial ischemia.

Kiewitz R., Acklin C., Minder E., Huber P.R., Schafer B.W., Heizmann C.W.

Biochem. Biophys. Res. Commun. 274:865-871(2000) · Mapped (1)

Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR.

Margue C.M., Bernasconi M., Barr F.G., Schafer B.W.

Oncogene 19:2921-2929(2000)

S100A13. Biochemical characterization and subcellular localization in different cell lines.

Ridinger K., Schafer B.W., Durussel I., Cox J.A., Heizmann C.W.

J. Biol. Chem. 275:8686-8694(2000)

The S100 family of EF-hand calcium-binding proteins: functions and pathology.

Schafer B.W., Heizmann C.W.

Trends Biochem. Sci. 21:134-140(1996) · Mapped (3)

Purification and characterization of the recombinant human calcium-binding S100 proteins CAPL and CACY.

Pedrocchi M., Schafer B.W., Durussel I., Cox J.A., Heizmann C.W.

Biochemistry 33:6732-6738(1994)

Inhibition of differentiation in myoblasts deprived of the interferon-related protein PC4.

Guardavaccaro D., Ciotti M.T., Schafer B.W., Montagnoli A., Tirone F.

Cell Growth Differ. 6:159-169(1995) · Mapped (9)

to top of page·

Page 1 of 1